Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

Letter from Abel Lajtha on Occasion of the 40th Anniversary of Neurochemical Research.

Lajtha A.

Neurochem Res. 2016 Feb;41(1-2):3-4. doi: 10.1007/s11064-016-1832-1. No abstract available.

PMID:
26907602
2.

Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.

Smith RC, Amiaz R, Si TM, Maayan L, Jin H, Boules S, Sershen H, Li C, Ren J, Liu Y, Youseff M, Lajtha A, Guidotti A, Weiser M, Davis JM.

PLoS One. 2016 Jan 5;11(1):e0143490. doi: 10.1371/journal.pone.0143490. eCollection 2016.

3.

Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study.

Smith RC, Boules S, Mattiuz S, Youssef M, Tobe RH, Sershen H, Lajtha A, Nolan K, Amiaz R, Davis JM.

Schizophr Res. 2015 Oct;168(1-2):260-6. doi: 10.1016/j.schres.2015.06.011. Epub 2015 Jul 17.

PMID:
26190299
4.

DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients.

Auta J, Smith RC, Dong E, Tueting P, Sershen H, Boules S, Lajtha A, Davis J, Guidotti A.

Schizophr Res. 2013 Oct;150(1):312-8. doi: 10.1016/j.schres.2013.07.030. Epub 2013 Aug 12.

5.

Welcome new editor-in-chief.

Lajtha A.

Neurochem Res. 2011 Dec;36(12):2205-6. doi: 10.1007/s11064-011-0610-3. No abstract available.

PMID:
21993541
6.

Nicotine: alcohol reward interactions.

Lajtha A, Sershen H.

Neurochem Res. 2010 Aug;35(8):1248-58. doi: 10.1007/s11064-010-0181-8. Epub 2010 May 25. Review.

PMID:
20499168
7.

Special issue in honor of professor Armen Galoyan. Preface.

Lajtha A.

Neurochem Res. 2010 Jun;35(6):835-6. doi: 10.1007/s11064-010-0166-7. No abstract available.

PMID:
20411325
8.

Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.

Smith RC, Zhubi A, Maloku E, Sershen H, Lajtha A, Davis JM, Costa E, Guidotti A.

Schizophr Res. 2010 Jun;119(1-3):269-70. doi: 10.1016/j.schres.2010.02.1064. Epub 2010 Mar 23. No abstract available.

PMID:
20335008
9.

Effect of nicotine and cocaine on neurofilaments and receptors in whole brain tissue and synaptoneurosome preparations.

Kovacs K, Lajtha A, Sershen H.

Brain Res Bull. 2010 Apr 29;82(1-2):109-17. doi: 10.1016/j.brainresbull.2010.02.008. Epub 2010 Feb 25.

PMID:
20188799
10.

Heterogeneity of reward mechanisms.

Lajtha A, Sershen H.

Neurochem Res. 2010 Jun;35(6):851-67. doi: 10.1007/s11064-009-0096-4. Epub 2009 Dec 12. Review.

PMID:
20012687
11.

Differences between nicotine and cocaine-induced conditioned place preferences.

Sershen H, Hashim A, Lajtha A.

Brain Res Bull. 2010 Jan 15;81(1):120-4. doi: 10.1016/j.brainresbull.2009.07.015.

PMID:
19665529
12.

The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.

Sershen H, Shearman E, Fallon S, Chakraborty G, Smiley J, Lajtha A.

Brain Res Bull. 2009 Aug 14;79(6):458-62. doi: 10.1016/j.brainresbull.2009.04.005. Epub 2009 Apr 21.

PMID:
19389462
13.

An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes.

Zhubi A, Veldic M, Puri NV, Kadriu B, Caruncho H, Loza I, Sershen H, Lajtha A, Smith RC, Guidotti A, Davis JM, Costa E.

Schizophr Res. 2009 Jun;111(1-3):115-22. doi: 10.1016/j.schres.2009.03.020. Epub 2009 Apr 21.

14.

GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum.

Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC.

Neuropharmacology. 2009 Apr;56(5):915-21. doi: 10.1016/j.neuropharm.2009.01.021. Epub 2009 Feb 6.

15.

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.

Smith RC, Lindenmayer JP, Davis JM, Cornwell J, Noth K, Gupta S, Sershen H, Lajtha A.

Schizophr Res. 2009 May;110(1-3):149-55. doi: 10.1016/j.schres.2009.02.001. Epub 2009 Feb 28.

PMID:
19251401
16.

Nicotine-induced monoamine neurotransmitter changes in the brain of young rats.

Shearman E, Fallon S, Sershen H, Lajtha A.

Brain Res Bull. 2008 Aug 15;76(6):626-39. doi: 10.1016/j.brainresbull.2008.03.017. Epub 2008 Apr 23.

PMID:
18598854
17.

Interrelated mechanisms in reward and learning.

Lajtha A.

Neurochem Int. 2008 Jan;52(1-2):73-9. Epub 2007 Sep 4. Review.

PMID:
17935832
18.

Food reward-induced neurotransmitter changes in cognitive brain regions.

Fallon S, Shearman E, Sershen H, Lajtha A.

Neurochem Res. 2007 Oct;32(10):1772-82. Epub 2007 Aug 25.

PMID:
17721820
19.

Apology to the journal.

Lajtha A.

Neurochem Res. 2006 Oct;31(10):1295. No abstract available.

PMID:
17009110
20.

The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas.

Fallon S, Shearman E, Sershen H, Lajtha A.

Neurochem Res. 2007 Apr-May;32(4-5):535-53. Epub 2006 Aug 15.

PMID:
16909314
21.

Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.

Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.

Brain Res Bull. 2006 Mar 31;69(2):204-13. Epub 2005 Dec 21.

PMID:
16533671
22.

Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function.

Shearman E, Rossi S, Sershen H, Hashim A, Lajtha A.

Neurochem Res. 2005 Aug;30(8):1055-66.

PMID:
16258855
23.

The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes.

Rossi S, Singer S, Shearman E, Sershen H, Lajtha A.

Neurochem Res. 2005 Apr;30(4):541-58.

PMID:
16076024
24.

Regional heterogeneity of nicotine effects on neurotransmitters in rat brains in vivo at low doses.

Rossi S, Singer S, Shearman E, Sershen H, Lajtha A.

Neurochem Res. 2005 Jan;30(1):91-103.

PMID:
15756937
25.

Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.

Singer S, Rossi S, Verzosa S, Hashim A, Lonow R, Cooper T, Sershen H, Lajtha A.

Neurochem Res. 2004 Sep;29(9):1779-92.

PMID:
15453274
26.

Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.

Pomara N, Willoughby LM, Hashim A, Sershen H, Sidtis JJ, Wesnes K, Greenblatt DJ, Lajtha A.

Neurochem Res. 2004 Jul;29(7):1391-8.

PMID:
15202770
27.

The possible role of glutamate uptake in metaphit-induced seizures.

Lipovac MN, Holland T, Poleksic A, Killian C, Lajtha A.

Neurochem Res. 2003 May;28(5):723-31.

PMID:
12716023
28.

Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens.

Sziráki I, Sershen H, Hashim A, Lajtha A.

Neurochem Res. 2002 Mar;27(3):253-61.

PMID:
11958525
29.

Characterization of multiple sites of action of ibogaine.

Sershen H, Hashim A, Lajtha A.

Alkaloids Chem Biol. 2001;56:115-33. Review. No abstract available.

PMID:
11705104
30.

Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum.

Balla A, Hashim A, Burch S, Javitt DC, Lajtha A, Sershen H.

Neurochem Res. 2001 Sep;26(8-9):1001-6.

PMID:
11699927
31.

Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats.

Sziraki, Lipovac MN, Hashim A, Sershen H, Allen D, Cooper T, Czobor P, Lajtha A.

Neurochem Res. 2001 Jun;26(6):609-17.

PMID:
11519721
32.

Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor.

Sershen H, Hashim A, Lajtha A.

Brain Res Bull. 2000 Oct;53(3):353-7.

PMID:
11113592
33.

Inhibition of striatal dopamine release by glycine and glycyldodecylamide.

Javitt DC, Sershen H, Hashim A, Lajtha A.

Brain Res Bull. 2000 Jun;52(3):213-6.

PMID:
10822163
34.

The effect of cotinine on nicotine- and cocaine-induced dopamine release in the nucleus accumbens.

Sziráki I, Sershen H, Benuck M, Lipovac M, Hashim A, Cooper TB, Allen D, Lajtha A.

Neurochem Res. 1999 Nov;24(11):1471-8.

PMID:
10555788
35.

Differences in receptor system participation between nicotine- and cocaine-induced dopamine overflow in nucleus accumbens.

Sziraki I, Sershen H, Benuck M, Hashim A, Lajtha A.

Ann N Y Acad Sci. 1999 Jun 29;877:800-2. No abstract available.

PMID:
10415708
36.

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

Javitt DC, Balla A, Sershen H, Lajtha A.

Biol Psychiatry. 1999 Mar 15;45(6):668-79.

PMID:
10187996
37.
38.

Receptor systems participating in nicotine-specific effects.

Sziráki I, Sershen H, Benuck M, Hashim A, Lajtha A.

Neurochem Int. 1998 Nov;33(5):445-57.

PMID:
9874095
39.

Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release.

Sershen H, Hashim A, Lajtha A.

Brain Res. 1998 Aug 10;801(1-2):67-71.

PMID:
9729284
40.

Alteration of protease levels in different brain areas of suicide victims.

Banay-Schwartz M, DeGuzman T, Faludi G, Lajtha A, Palkovits M.

Neurochem Res. 1998 Jul;23(7):953-9.

PMID:
9690737
41.

Effects of arginine vasopressin and atriopeptin on chloride uptake in cultured astroglia.

Katay L, Latzkovits L, Fonagy A, Janka Z, Lajtha A.

Neurochem Res. 1998 Jun;23(6):831-6.

PMID:
9572671
42.
43.

Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide.

Javitt DC, Sershen H, Hashim A, Lajtha A.

Neuropsychopharmacology. 1997 Sep;17(3):202-4.

44.

Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes.

Bencsics A, Sershen H, Baranyi M, Hashim A, Lajtha A, Vizi ES.

Brain Res. 1997 Jul 4;761(2):236-43.

PMID:
9252021
45.

Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.

Sershen H, Balla A, Lajtha A, Vizi ES.

Neuroscience. 1997 Mar;77(1):121-30.

PMID:
9044380
46.

Effects of iminodipropionitrile on cerebral amino acid levels.

Toth E, Lajtha A, Vizi ES.

Brain Res Bull. 1997;44(6):715-8.

PMID:
9421135
47.

Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices.

Kiss JP, Windisch K, Balla A, Sershen H, Lajtha A.

Brain Res Bull. 1997;43(3):257-62.

PMID:
9227834
48.

Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors.

Sershen H, Hashim A, Lajtha A.

Brain Res Bull. 1997;42(3):161-8. Review.

PMID:
8995326
49.

Changes in brain protease activity in aging.

Benuck M, Banay-Schwartz M, DeGuzman T, Lajtha A.

J Neurochem. 1996 Nov;67(5):2019-29.

PMID:
8863509
50.

Metabolism of (-)-deprenyl and PF-(-)-deprenyl in brain after central and peripheral administration.

Lajtha A, Sershen H, Cooper T, Hashim A, Gaál J.

Neurochem Res. 1996 Oct;21(10):1155-60.

PMID:
8923474

Supplemental Content

Loading ...
Support Center